System C has acquired medicines administration specialist Wellsky in a bid to strengthen its digital affected person document (EPR) providing and compete with US rivals.
WellSky Worldwide, previously generally known as JAC, is greatest recognized for its digital prescribing and medicines administration (EPMA) options. These options are utilized by round 200 NHS trusts and Well being Boards throughout England, Scotland, Wales and Northern Eire, along with a variety of worldwide shoppers.
The corporate, which employs 70 workers within the UK, has probably the most in depth pharmacy and EPMA product choices within the UK NHS market, together with specialist areas of prescribing like chemotherapy and paediatrics.
System C described the acquisition as extremely strategic and mentioned it might combine Wellsky into its Careflow cloud EPR suite, together with medical collaboration, care planning, digital observations and affected person stream.
“System C will make investments considerably in product innovation, preserve interoperability with all hospital software program techniques and third-party suppliers,” the corporate mentioned in a press release.
Dr Ian Denley, joint CEO at System C, added: “WellSky Worldwide leads the market in medicines administration options and has a protracted observe document of collaboration with clinicians throughout the NHS. Its extremely developed medical merchandise are held in the perfect regard by customers, and we’re delighted that they’ve joined the System C group.”
Markus Baw, joint CEO of System C informed Digital Well being Information that whereas the corporate “has prescribing module” they don’t have “the breadth that Wellsky covers” as “EPMA may be very complicated”.
He additionally confirmed that work had already begun to combine Wellsky into System C’s EPR.
“It’s actually good having prescribing absolutely built-in into an EPR as you will get numerous advantages,” he defined.
Cerner and Epic have built-in EPMA capabilities and System C hope the acquisition will assist them compete with their NHS rivals.
WellSky’s in depth EPMA product portfolio encompasses essential care, emergency care, theatres, managed medication and cell options for provision of bedside closed loop options.
Bolton mentioned that the addition of a closed loop EPMA answer will allow System C to assist its shoppers get to HIMSS 6 and seven accreditation, a benchmark promoted by the International Digital Exemplar programme.
Robert Tysall-Blay, CEO of WellSky Worldwide, added: “System C is a superb cultural match for us and has the ambition, scale and vary of merchandise we have to supply a world class medicines administration platform as a part of an Built-in EPR.”
The phrases of the deal weren’t disclosed